Hydroxyfasudil hydrochloride hydrate
SIGMA/H4413 - ≥98% (HPLC), solid
Synonym: 1-
CAS Number: 155558-32-0 (anhydrous)
Empirical Formula (Hill Notation): C14H17N3O3S · HCl · xH2O
Molecular Weight: 343.83 (anhydrous basis)
MDL Number: MFCD06411567
Linear Formula: C14H17N3O3S · HCl · xH2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| composition | The two peaks show the equilibrim between the two tautomers |
| form | solid |
| InChI | 1S/C14H17N3O3S.ClH/c18-14 |
| InChI key | XWWFOUVDVJGNNG-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl[H].Oc1nccc2c(cccc12)S( |
| solubility | H2O: >5 mg/mL |
| storage temp. | 2-8°C |
| Application: | Hydroxyfasudil hydrochloride hydrate has been used as a ROCK inhibitor to study the role of different signaling pathways in the chemokines CCL19 and CCL21, the CCR7 ligands mediated effects on migratory and prosurvival, in CLL cells. |
| Biochem/physiol Actions: | Hydroxyfasudil possessantispastic action. It is an active metabolite of fasudil. Hydroxyfasudil might enhance the dynamics of blood flow and prevent damage caused by neutrophils. |
| Biochem/physiol Actions: | Rho-kinase inhibitor. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


